USFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult patients with metastatic Urothelial Carcinoma: Bristol Myers Squibb Ruchika Sharma9 March 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab), in combination...
Robotic-assisted surgery for gallbladder cancer as effective as traditional surgery, finds BU study Dr. Kamal Kant Kohli9 March 2024 12:30 AM ISTEach year, approximately 2,000 people die annually of gallbladder cancer (GBC) in the U.S., with only one in five cases diagnosed at an early stage....
HPV vaccines not just for females, it is useful for males too! Prof Dr Juggal Kishore explains MD Bureau8 March 2024 12:48 PM ISTThe combination of HPV vaccination and cervical screening can provide the greatest protection against cervical cancer. Also, HPV vaccination reduces...
GMC Jammu begins cancer genetic testing on NGS technology Kajal Rajput8 March 2024 11:15 AM ISTJammu: In a first of its kind, the Department of Microbiology, Government Medical College and Hospital Jammu has successfully started genetic testing...
Gilead Sciences, Merus collaborate to discover novel antibody-based trispecific T-cell engagers Ruchika Sharma7 March 2024 11:59 AM ISTFoster City: Gilead Sciences, Inc. and Merus N.V. have announced a research collaboration, option and license agreement to discover novel dual...
8-year-old Yemeni boy undergoes rare thyroid cancer surgery at Jaslok Hospital Kajal Rajput7 March 2024 10:30 AM ISTMumbai: In a remarkable medical achievement, Jaslok Hospital & Research Centre recently provided comprehensive and successful treatment to an...
Treatment of H. pylori infection may reduce risk of colorectal cancer and associated mortality: Study Aditi7 March 2024 1:45 AM ISTAlthough H. pylori infection does not itself cause illness but, chronic infection is associated with long-lasting inflammation in the stomach, which...
EMA validates marketing authorisation applications for AstraZeneca, Daiichi Sankyo datopotamab deruxtecan in lung, breast cancer Ruchika Sharma6 March 2024 3:25 PM ISTCambridge: The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for AstraZeneca and Daiichi Sankyo’s...
Exploring the genome of male breast cancer Anshika Mishra5 March 2024 8:30 PM ISTAccording to a study conducted by researchers at Weill Cornell Medicine, distinct genetic alterations in the tumour genome of male breast cancer could...
SII boosts cervical cancer shots supply ahead of govt mass drive Ruchika Sharma4 March 2024 2:43 PM ISTPoonawalla expects the vaccine to be "substantially, probably eight times, cheaper" when supplied to the government.
New microbiome discovery may enhance immunotherapy for various rare cancers Anshika Mishra4 March 2024 1:00 AM ISTResearchers from the Wellcome Sanger Institute, the Olivia Newton-John Cancer Research Institute in Australia have identified specific strains of...
Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment Ruchika Sharma2 March 2024 2:33 PM ISTRaritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
